This #clinicaltrial is for patients with recurrent #glioblastoma.
ReSPECT-GBM Patient Story | Jim, Recurrent Glioblastoma SurvivorПодробнее
The FRONTIER study uses Y-90 for recurrent GBM treatment.Подробнее
Re-irradiation in recurrent glioblastoma: PET- or MRI-based? A randomized clinical trialПодробнее
Webinar: Positive Preliminary Phase 1a Data for CLTX CAR T in Recurrent Brain Cancer Clinical TrialПодробнее
This is Your Brain: New Treatments for GlioblastomaПодробнее
Brain Tumor Clinical Trials At The Cleveland ClinicПодробнее
Glioblastoma Clinical Trial: The FRONTIER StudyПодробнее
Early clinical trial results show dramatic progress against glioblastoma tumorsПодробнее
A patient takes part in new Phase 1 clinical trial for patients with recurrent glioblastomaПодробнее
Clinical Trial with Pembrolizumab in Relapsed GBM Patients - Robert Prins, PhDПодробнее
ReSPECT-GBM Clinical Trial for Recurrent GlioblastomaПодробнее
What is the ReSPECT™-GBM Clinical Trial and its Current Status?Подробнее
Webinar: GammaTile® Therapy: Brain Brachytherapy Powerfully Reimagined!Подробнее
GBM Workshop 2021 – Clinical Trial of BBB Disruption with Implantable Ultrasound for Recurrent GBMПодробнее
Michael Canney: BBB Opening with SonoCloud-9 Ultrasound Device in Recurrent Glioblastoma PatientsПодробнее
Immunotherapy for Glioblastoma: Overcoming Resistance with Linda M. Liau, MD, PhD, MBAПодробнее
Experimental Therapies & Agents in Clinical Trials for Gliomas: UCLA Brain Tumor Virtual ConferenceПодробнее
Clinical Trials for Brain TumorsПодробнее
DCVax-L Phase 3 Clinical Trial ResultsПодробнее
Historic First-in-Human Sonodynamic Therapy Clinical Trial for GlioblastomaПодробнее